MacroGenics
MGNX
#8650
Rank
ยฃ0.17 B
Marketcap
ยฃ2.77
Share price
-7.73%
Change (1 day)
122.94%
Change (1 year)

MacroGenics (MGNX) - Total assets

Total assets on the balance sheet as of March 2026 : ยฃ0.16 Billion

According to MacroGenics's latest financial reports the company's total assets are ยฃ0.16 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

MacroGenics - Total assets on balance sheet (from 2012 to 2026)

Total assets by year

Year Total assets Change
2025-12-31ยฃ0.19 B-8.53%
2024-12-31ยฃ0.20 B-10.99%
2023-12-31ยฃ0.23 B1.04%
2022-12-31ยฃ0.23 B-6.66%
2021-12-31ยฃ0.24 B-10.62%
2020-12-31ยฃ0.27 B16.59%
2019-12-31ยฃ0.23 B-8.92%
2018-12-31ยฃ0.26 B-5.42%
2017-12-31ยฃ0.27 B9.67%
2016-12-31ยฃ0.25 B4.05%
2015-12-31ยฃ0.24 B117.07%
2014-12-31ยฃ0.11 B46.47%
2013-12-31ยฃ76.25 M129.31%
2012-12-31ยฃ33.25 M-17.54%
2011-12-31ยฃ40.32 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
ยฃ155.43 B 95,193.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ87.27 B 53,406.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ69.25 B 42,357.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ42.13 B 25,730.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ96.34 B 58,964.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ64.74 B 39,591.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
ยฃ0.55 B 238.20%๐Ÿ‡บ๐Ÿ‡ธ USA